190656-34-9 Usage
General Description
5-Bromo-2-fluorobenzylamine is a chemical compound with the molecular formula C7H6BrFN. It is a derivative of benzylamine and contains a bromine and fluorine atom attached to the benzyl ring. 5-Bromo-2-fluorobenzylamine. is commonly used in organic chemistry as a building block for the synthesis of various pharmaceuticals and agrochemicals. It is also utilized in the research and development of new chemical compounds. Due to its reactivity and functional group, 5-Bromo-2-fluorobenzylamine has applications in the production of a wide range of organic compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 190656-34-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,0,6,5 and 6 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 190656-34:
(8*1)+(7*9)+(6*0)+(5*6)+(4*5)+(3*6)+(2*3)+(1*4)=149
149 % 10 = 9
So 190656-34-9 is a valid CAS Registry Number.
InChI:InChI=1/C7H7BrFN/c8-6-1-2-7(9)5(3-6)4-10/h1-3H,4,10H2
190656-34-9Relevant articles and documents
SULFONYL-SUBSTITUTED BENZOHETEROCYCLIC DERIVATIVE, PREPARATION METHOD AND MEDICAL USE THEREOF
-
Paragraph 0138; 0151, (2019/10/23)
The present invention relates to a sulfonyl-substituted benzoheterocyclic derivative, a preparation method and medical use thereof. Particularly, disclosed is a compound of formula (I) or a pharmaceutically acceptable salt, stereoisomer, solvate, or prodrug thereof, and a preparation method and application thereof. The definition of each group in the formula can be found in the specification and the claims.
Methods and fluorinated compositions for treating amyloid-related diseases
-
Page/Page column 63, (2008/06/13)
Methods, compounds, pharmaceutical compositions and kits are described for treating or preventing amyloid-related disease. Also described are methods, compounds, pharmaceutical compositions and kits for detecting, diagnosing, monitoring and treating or preventing amyloid-related disease.
